Tyler E. Callese, MD is a vascular and interventional specialist and partner at Gaston Radiology, P.A., practicing at CaroMont Regional Medical Center. His practice is dedicated to treating complex vascular, oncologic, and venous disease through image-guided, minimally invasive techniques.
Dr. Callese is a vascular and interventional specialist whose practice encompasses the full breadth of image-guided therapy, with particular depth in complex venous disease, embolotherapy, and interventional oncology. Interventional radiology treats disease from within the body — navigating catheters and devices through the vascular system under real-time imaging — allowing many conditions that once required open surgery to be addressed through an access site only millimeters wide, frequently on an outpatient basis.
He completed his integrated Interventional Radiology residency at the University of California, Los Angeles, where he served as Chief Resident in both Diagnostic and Interventional Radiology and was recognized with the Ahn Au Award for Clinical Excellence, the RSNA Roentgen Resident Research Award, and Resident of the Year honors. He earned his medical degree from Wake Forest University School of Medicine and his undergraduate degree in Biochemistry, cum laude, from Middlebury College.
Since joining Gaston Radiology, P.A. as a partner in 2024, Dr. Callese has served as the primary operator for complex venous intervention at CaroMont Regional Medical Center. He contributes to institutional quality and program development through the hospital's Pulmonary Embolism Quality Committee and Trauma Services Committee.
In addition to clinical practice, Dr. Callese serves as an independent consultant, providing interventional and endovascular strategy consulting to investment firms and medical device companies — evaluating technologies, assessing market readiness, and informing next-generation product design. He leverages a highly active clinical practice and health-system leadership experience to translate real-world interventional and endovascular needs into actionable innovation strategy.
His research has been published in journals including European Radiology, the Journal of Vascular and Interventional Radiology, and CardioVascular and Interventional Radiology, with contributions spanning genicular artery embolization, prostatic artery embolization, venous thromboembolism, and health systems research.
Outside of practice, Dr. Callese is an avid skier and surfer, and maintains long-standing interests in modern fiction, history, and behavioral economics.
Bachelor of Arts in Biochemistry, cum laude, with a minor in Economics. Varsity athlete in crew and baseball.
Doctor of Medicine, with a Certificate in Global Health. Founder and Director of the Navigating Medical School Program; recipient of the Isadore and Rachel Meschan Award for Academic Excellence in Radiological Sciences.
Surgical internship at the University of California, Los Angeles, providing an operative foundation that continues to inform procedural judgment and patient selection.
Comprehensive training in vascular, oncologic, and venous intervention at one of the nation's leading academic IR programs. Served as Chief Resident of Diagnostic and Interventional Radiology (2022–2023) and Chief Resident/Fellow of Interventional Radiology (2023–2024). Concurrently served as Associate Attending Physician in Diagnostic Radiology at UCLA Ronald Reagan, UCLA Santa Monica, and Martin Luther King Jr. Hospitals.
Ahn Au Award for Clinical Excellence RSNA Roentgen Research Award IR Resident of the YearCertified by the American Board of Radiology in Diagnostic and Interventional Radiology (2025); Registered Physician in Vascular Interpretation (RPVI, 2024). Licensed in North Carolina.
Interventional radiologist and partner in the hospital-based practice serving CaroMont Regional Medical Center, serving as primary operator for complex venous intervention. Member of the Pulmonary Embolism Quality Committee, Trauma Services Committee, and Physician Recruitment Committee.
Advises investment firms and medical device companies on interventional and endovascular strategy — evaluating technologies, assessing market readiness, and informing next-generation product design — translating real-world clinical needs into actionable innovation strategy.
Each condition below is treated through a catheter, needle, or implant — rather than an open incision — guided in real time by advanced imaging.
Mechanical and pharmacomechanical thrombectomy for thrombus in the extremities, pelvis, and pulmonary arteries — restoring flow expeditiously and limiting long-term venous sequelae.
Iliocaval stent reconstruction and treatment of chronic venous occlusions — recanalizing long-standing blockages of the deep venous system and restoring durable flow through the iliac veins and vena cava.
Diagnosis and embolization for pelvic venous congestion and related venous insufficiency, including iliocaval stenting under intravascular ultrasound guidance.
Placement and retrieval of inferior vena cava filters within a structured surveillance program, ensuring retrievable filters are followed to appropriate removal.
An outpatient, incision-free alternative to surgery for benign prostatic hyperplasia, performed through a small radial or femoral access site.
A minimally invasive treatment for knee osteoarthritis pain that targets abnormal vascularity around the joint while preserving the joint itself. Dr. Callese has published peer-reviewed research on GAE technique and outcomes.
Y90 radioembolization delivering targeted internal radiation directly to hepatic tumors, and image-guided thermal ablation of lung, kidney, bone, and liver tumors — concentrating treatment within the tumor while sparing healthy tissue.
Minimally invasive treatment of painful vertebral compression fractures, including kyphoplasty, vertebroplasty, targeted ablation, and SpineJack implant-based vertebral restoration.
Endovascular repair of renal, visceral, and splenic artery aneurysms — excluding the aneurysm from circulation through catheter-based techniques while preserving flow to the end organ.
Peer-reviewed research spanning genicular and prostatic artery embolization, venous thromboembolism, interventional techniques, medical education, and global health systems.
Every patient receives a dedicated consultation: a clear explanation of the diagnosis, a review of all appropriate treatment options, and a realistic discussion of expected recovery.
Referrals are reviewed prior to scheduling, with findings and recommendations communicated back to the referring practice. Same-day telephone triage is available for urgent venous and oncologic cases.
Dr. Callese is committed to expanding access to advanced image-guided therapies within the region — through institutional program development, quality committee work, and physician education.